Oregon Health & Science University

2018 Program schedule


FRIDAY MORNING

September 7 / Heart Failure and Electrophysiology

7:30 a.m.
Registration and breakfast

8:30 a.m.
Welcome

8:45 a.m.
Heart failure therapy in 2018: tailoring care
Akshay Desai, M.D., M.P.H.

9:15 a.m.
Pulmonary hypertension in left heart disease: you noticed it, now what?
Paul Forfia, M.D.

9:45 a.m.
Panel Q & A

10 a.m.
Break

10:30 a.m.
The device detected atrial fibrillation: now what?
Jeff Healey, M.D.

11 a.m.
Ventricular tachycardia ablation: epicardial this time, or is enough, enough.
William Stevenson, M.D.

11:30 a.m.
Panel Q & A

11:40 a.m.
Lunch


FRIDAY AFTERNOON

September 7 / Imaging and Vascular Medicine

1 p.m.
Noninvasive evaluation of systolic and diastolic function – what is considered state-of-the-art?
James Thomas, M.D.

1:30 p.m.
Cardio-oncology – the intersection of cancer and the heart
Edward Yeh, M.D.

2 p.m.
Panel Q & A

2:15 p.m.
Break

2:45 p.m.
Disruptive technology in vascular surgery – failures, success, and the future
Thomas Forbes, M.D.

3:15 p.m.
Pushing the boundaries of PVD: challenges and advances
Joshua Beckman, M.D.

3:45 p.m.
Panel Q & A

4 p.m.
Break

4:15 p.m.
KEYNOTE ADDRESS
From the artificial valve to the artificial heart: an innovator's journey
Albert Starr, M.D.

5 p.m.
Reception


SATURDAY MORNING

September 8 / Prevention and Structural Heart Disease

7:30 a.m.
Breakfast

8:15 a.m.
Welcome

8:30 a.m.
Challenges for lipid testing and treatment in the era of low LDL-c & novel therapies
Samia Mora, M.D.

9:00 a.m.
The science of diet: distilling it into daily practice
Pamela Morris, M.D.

9:30 a.m.
Panel Q & A

9:45 a.m.
Break

10:15 a.m.
The neglected valve: should we being doing more tricuspid disease?
Paul Sorajja, M.D.

10:45 a.m.
Emerging transcatheter therapies for mitral valve disease: are we ready?
Michael Mack, M.D.

11:15 a.m.
Panel Q & A

11:30 a.m.
Adjourn